Compounds > amphetamine

amphetamine and pergolide

amphetamine has been researched along with pergolide in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (50.00)	18.7374
1990's	2 (16.67)	18.2507
2000's	2 (16.67)	29.6817
2010's	2 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Davis, A; Jenner, P; Marsden, CD	1
Ståhle, L; Ungerstedt, U	1
Goiny, M; Uvnäs-Moberg, K	1
Arnt, J	1
Fuller, RW; Hymson, DL; Hynes, MD; Langer, DH; Pearson, DV	1
Arnt, J; Hyttel, J	1
Johnson, KM; Leventer, SM	1
Damhaut, P; Dethy, S; Goldman, S; Laute, MA	1
Auerbach, PP; Cadenhead, K; Eastvold, A; Geyer, MA; Karban, B; Ploum, Y; Stephany, N; Swerdlow, NR	1

Reviews

1 review(s) available for amphetamine and pergolide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

11 other study(ies) available for amphetamine and pergolide

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour. Psychopharmacology, 1990, Volume: 100, Issue:1 Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride	1990
Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis. Psychopharmacology, 1989, Volume: 97, Issue:4 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Corpus Striatum; Dialysis; Exploratory Behavior; Habituation, Psychophysiologic; Male; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Yawning	1989
Effects of dopaminomimetics on the secretion of VIP-like immunoreactivity in conscious dogs. Peptides, 1986, Volume: 7 Suppl 1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Apomorphine; Benzazepines; Dogs; Ergolines; Nitroglycerin; Pergolide; Piperidines; Prazosin; Receptors, Dopamine; Somatostatin; Vasoactive Intestinal Peptide	1986
Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats. Psychopharmacology. Supplementum, 1985, Volume: 2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Brain; Ergolines; Humans; Hydroxydopamines; Oxidopamine; Pergolide; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior	1985
Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive rats. Pharmacology, biochemistry, and behavior, 1985, Volume: 23, Issue:3 Topics: Amphetamine; Animals; Dopamine; Dose-Response Relationship, Drug; Ergolines; Hypertension; Motor Activity; Pergolide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine	1985
Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. European journal of pharmacology, 1984, Jul-13, Volume: 102, Issue:2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Antipsychotic Agents; Appetite Depressants; Benzamides; Benzazepines; Catalepsy; Clopenthixol; Ergolines; Flupenthixol; Humans; Hydroxydopamines; Male; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior	1984
Effects of phencyclidine on the release of radioactivity from rat striatal slices labeled with [3H]choline. The Journal of pharmacology and experimental therapeutics, 1983, Volume: 225, Issue:2 Topics: Acetylcholine; Amphetamine; Animals; Atropine; Calcium; Choline; Corpus Striatum; Dose-Response Relationship, Drug; Ergolines; Male; Oxotremorine; Pergolide; Phencyclidine; Rats; Rats, Inbred Strains	1983
Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Synergism; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Microdialysis; Motor Activity; Neostriatum; Neurons; Oxidopamine; Parkinson Disease, Secondary; Pergolide; Rats; Rats, Wistar	1999
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology, 2002, Volume: 161, Issue:2 Topics: Adolescent; Adult; Amantadine; Amphetamine; Analysis of Variance; Blood Pressure; Bromocriptine; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Male; Pergolide; Psychomotor Performance; Reflex, Startle; Time Factors	2002